Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-01-02 @ 6:53 AM
Study NCT ID:
NCT00058604
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2003-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Sponsor:
Baylor College of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
H9454
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None